Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
23-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
23-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Journals
Journal #3664
advertisement
Polymers
21
Showing records 1 to 21 |
Display all abstracts in
Polymers
104442
Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy
Akulo KA
Polymers
2022; 14:
105049
Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Yao K
Polymers
2022; 14:
105050
PLA-PEG Implant as a Drug Delivery System in Glaucoma Surgery: Experimental Study
Germanova VN
Polymers
2022; 14:
105049
Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Liang X
Polymers
2022; 14:
105050
PLA-PEG Implant as a Drug Delivery System in Glaucoma Surgery: Experimental Study
Karlova EV
Polymers
2022; 14:
104442
Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy
Adali T; Moyo MTG
Polymers
2022; 14:
105050
PLA-PEG Implant as a Drug Delivery System in Glaucoma Surgery: Experimental Study
Volova LT
Polymers
2022; 14:
105049
Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Zhang G
Polymers
2022; 14:
104442
Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy
Bodamyali T
Polymers
2022; 14:
105049
Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Rong Y
Polymers
2022; 14:
105050
PLA-PEG Implant as a Drug Delivery System in Glaucoma Surgery: Experimental Study
Zolotarev AV
Polymers
2022; 14:
105049
Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Zhang Q
Polymers
2022; 14:
105050
PLA-PEG Implant as a Drug Delivery System in Glaucoma Surgery: Experimental Study
Rossinskaya VV
Polymers
2022; 14:
105049
Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Liao Q
Polymers
2022; 14:
105050
PLA-PEG Implant as a Drug Delivery System in Glaucoma Surgery: Experimental Study
Zakharov ID; Korigodskiy AR
Polymers
2022; 14:
105049
Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Zhang H
Polymers
2022; 14:
105050
PLA-PEG Implant as a Drug Delivery System in Glaucoma Surgery: Experimental Study
Boltovskaya VV
Polymers
2022; 14:
105049
Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Xi K
Polymers
2022; 14:
105050
PLA-PEG Implant as a Drug Delivery System in Glaucoma Surgery: Experimental Study
Nefedova IF
Polymers
2022; 14:
105049
Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Wang J
Polymers
2022; 14:
105050
PLA-PEG Implant as a Drug Delivery System in Glaucoma Surgery: Experimental Study
Radaykina MV
Polymers
2022; 14:
Issue
23-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept